IPO Trending
TRANSPACTSME / BSEListed
Transpact Enterprises

Incorporated in 2013, Maharashtra-based Transpact Enterprises Limited is a biotechnology startup focused on developing innovative and affordable solutions for specially-abled individuals. The company primarily designs, develops, and distributes the Vestibulator, a therapeutic device created to address vestibular dysfunctions. The Vestibulator is a co-patented technology of Transpact Enterprises and IRCC-IIT Bombay, and the company holds a license from the Society for Innovation and Entrepreneurship, IIT Bombay, to commercialize the product. While the design and customization of the device are handled in-house with the help of advanced software, the manufacturing process is outsourced to third-party vendors. Transpact Enterprises is dedicated to continuous innovation to enhance its offerings and improve the quality of life for its users.

₹130 - ₹130Open
Listed Price₹130.00
Listing Gain+0.00%

Subscription Status

0Updated 20 Oct 2026, 01:30 AM
Subscription PendingExchange subscription breakup is not available yet.

Category-wise demand has not been published yet. Check back after the exchange updates the live subscription feed.

Open Date26 Aug 2019
Close Date28 Aug 2019
Listing Date05 Sep 2019
Bidding status cross-verified with live IPO subscription numbers ↗BSE & NSE Bidding Portal Feed

About Transpact Enterprises IPO Subscription Demand

Live subscription status and bidding analysis for Transpact Enterprises (TRANSPACT) IPO. The issue is subscribed Tracking Live overall across Qualified Institutional Buyers (QIB), Non-Institutional Investors (NII/HNI), and Retail Individual Investors (RII). Check real-time grey market demand on our GMP Tracker or review full issue details, lot size, and price band on the IPO Details Page.

Frequently Asked Questions